Kenjo et al. treated humanized Duchenne muscular dystrophy (DMD) mice by intramuscular injection or limb perfusion with ionizable lipid TCL053-based LNPs encapsulating Cas9 mRNA and sgRNA targeting the dystrophin gene. This evidence concerns the gene DMD and Duchenne muscular dystrophy.